To determine whether galantamine’s effect on splenomegaly is mediated by its AChE inhibitory activity, we treated FMF-KI mice with huperzine A, a potent centrally- and peripherally-acting AchE inhibitor that is structurally different from galantamine. Here, ACHE is linked to Splenomegaly.